Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
2.310
+0.050 (2.21%)
Nov 21, 2024, 4:00 PM EST - Market closed
Oramed Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2021 | FY 2020 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Aug '21 Aug 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 93 | 93 | 471 | 544 | 640 | 110 | |
| Market Cap Growth | -5.37% | -80.20% | -13.48% | -15.00% | 479.35% | 34.51% | |
| Enterprise Value | -50 | -9 | 311 | 444 | 565 | 67 | |
| Last Close Price | 2.31 | 2.31 | 12.03 | 14.28 | 19.68 | 4.24 | |
| PE Ratio | 21.10 | 16.87 | - | - | - | - | |
| PS Ratio | - | 69.54 | 174.08 | 200.54 | 236.73 | 40.73 | |
| PB Ratio | 0.59 | 0.57 | 3.11 | 3.26 | 5.49 | - | |
| P/TBV Ratio | 0.64 | 0.57 | 3.10 | 3.27 | 5.53 | - | |
| EV/Sales Ratio | - | - | 115.15 | 163.83 | 208.87 | 24.59 | |
| Debt / Equity Ratio | 0.00 | 0.32 | 0.01 | 0.00 | 0.00 | - | |
| Asset Turnover | - | 0.01 | 0.02 | - | 0.03 | - | |
| Quick Ratio | 26.99 | 3.05 | 27.10 | 19.85 | 14.09 | - | |
| Current Ratio | 27.08 | 3.06 | 27.34 | 20.08 | 14.27 | - | |
| Return on Equity (ROE) | 2.89% | 3.24% | -23.77% | - | -30.78% | - | |
| Return on Assets (ROA) | -4.12% | -5.16% | -14.95% | - | -17.54% | - | |
| Return on Capital (ROIC) | -4.29% | -5.38% | -15.90% | - | -20.19% | - | |
| Earnings Yield | 4.79% | 5.93% | -7.77% | -6.44% | -3.48% | -19.89% | |
| FCF Yield | -8.51% | -11.32% | -6.04% | -6.14% | -3.37% | -23.31% | |
| Buyback Yield / Dilution | -2.51% | -4.02% | -5.08% | -30.36% | -16.71% | -18.81% | |
| Total Shareholder Return | -2.51% | -4.02% | -5.08% | -30.36% | -16.71% | -18.81% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.